Literature DB >> 24667911

Kinetic modeling without accounting for the vascular component impairs the quantification of [(11)C]PBR28 brain PET data.

Gaia Rizzo1, Mattia Veronese2, Matteo Tonietto1, Paolo Zanotti-Fregonara3, Federico E Turkheimer2, Alessandra Bertoldo1.   

Abstract

The positron emission tomography radioligand [(11)C]PBR28 targets translocator protein (18 kDa) (TSPO) and is a potential marker of neuroinflammation. [(11)C]PBR28 binding is commonly quantified using a two-tissue compartment model and an arterial input function. Previous studies with [(11)C]-(R)-PK11195 demonstrated a slow irreversible binding component to the TSPO proteins localized in the endothelium of brain vessels, such as venous sinuses and arteries. However, the impact of this component on the quantification of [(11)C]PBR28 data has never been investigated. In this work we propose a novel kinetic model for [(11)C]PBR28. This model hypothesizes the existence of an additional irreversible component from the blood to the endothelium. The model was tested on a data set of 19 healthy subjects. A simulation was also performed to quantify the error generated by the standard two-tissue compartmental model when the presence of the irreversible component is not taken into account. Our results show that when the vascular component is included in the model the estimates that include the vascular component (2TCM-1K) are more than three-fold smaller, have a higher time stability and are better correlated to brain mRNA TSPO expression than those that do not include the model (2TCM).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24667911      PMCID: PMC4050251          DOI: 10.1038/jcbfm.2014.55

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  30 in total

1.  [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.

Authors:  A Gerhard; R B Banati; G B Goerres; A Cagnin; R Myers; R N Gunn; F Turkheimer; C D Good; C J Mathias; N Quinn; J Schwarz; D J Brooks
Journal:  Neurology       Date:  2003-09-09       Impact factor: 9.910

Review 2.  The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology.

Authors:  J Gatliff; M Campanella
Journal:  Curr Mol Med       Date:  2012-05       Impact factor: 2.222

3.  Propofol decreases in vivo binding of 11C-PBR28 to translocator protein (18 kDa) in the human brain.

Authors:  Christina S Hines; Masahiro Fujita; Sami S Zoghbi; Jin Su Kim; Zenaide Quezado; Peter Herscovitch; Ning Miao; Maria D Ferraris Araneta; Cheryl Morse; Victor W Pike; Julia Labovsky; Robert B Innis
Journal:  J Nucl Med       Date:  2012-11-12       Impact factor: 10.057

4.  Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

Authors:  M Cosenza-Nashat; M-L Zhao; H-S Suh; J Morgan; R Natividad; S Morgello; S C Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12-11       Impact factor: 8.090

5.  In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

Authors:  William C Kreisl; Chul Hyoung Lyoo; Meghan McGwier; Joseph Snow; Kimberly J Jenko; Nobuyo Kimura; Winston Corona; Cheryl L Morse; Sami S Zoghbi; Victor W Pike; Francis J McMahon; R Scott Turner; Robert B Innis
Journal:  Brain       Date:  2013-06-17       Impact factor: 13.501

6.  Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA.

Authors:  I Suridjan; P M Rusjan; A N Voineskos; T Selvanathan; E Setiawan; A P Strafella; A A Wilson; J H Meyer; S Houle; R Mizrahi
Journal:  Neuroimage       Date:  2013-09-21       Impact factor: 6.556

7.  Reference and target region modeling of [11C]-(R)-PK11195 brain studies.

Authors:  Federico E Turkheimer; Paul Edison; Nicola Pavese; Federico Roncaroli; Alexander N Anderson; Alexander Hammers; Alexander Gerhard; Rainer Hinz; Yan F Tai; David J Brooks
Journal:  J Nucl Med       Date:  2007-01       Impact factor: 10.057

8.  The predictive power of brain mRNA mappings for in vivo protein density: a positron emission tomography correlation study.

Authors:  Gaia Rizzo; Mattia Veronese; Rolf A Heckemann; Sudhakar Selvaraj; Oliver D Howes; Alexander Hammers; Federico E Turkheimer; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2014-02-05       Impact factor: 6.200

9.  Identifying improved TSPO PET imaging probes through biomathematics: the impact of multiple TSPO binding sites in vivo.

Authors:  Qi Guo; David R Owen; Eugenii A Rabiner; Federico E Turkheimer; Roger N Gunn
Journal:  Neuroimage       Date:  2012-01-10       Impact factor: 6.556

10.  Image-derived input function for human brain using high resolution PET imaging with [C](R)-rolipram and [C]PBR28.

Authors:  Paolo Zanotti-Fregonara; Jeih-San Liow; Masahiro Fujita; Elodie Dusch; Sami S Zoghbi; Elise Luong; Ronald Boellaard; Victor W Pike; Claude Comtat; Robert B Innis
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

View more
  60 in total

1.  Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.

Authors:  Peter S Bloomfield; Sudhakar Selvaraj; Vincenzo de Paola; Oliver D Howes; Mattia Veronese; Gaia Rizzo; Alessandra Bertoldo; David R Owen; Michael Ap Bloomfield; Ilaria Bonoldi; Nicola Kalk; Federico Turkheimer; Philip McGuire
Journal:  Am J Psychiatry       Date:  2015-10-16       Impact factor: 18.112

Review 2.  Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.

Authors:  Matteo Tonietto; Gaia Rizzo; Mattia Veronese; Masahiro Fujita; Sami S Zoghbi; Paolo Zanotti-Fregonara; Alessandra Bertoldo
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-14       Impact factor: 6.200

3.  Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies.

Authors:  Junchao Tong; Belinda Williams; Pablo M Rusjan; Romina Mizrahi; Jean-Jacques Lacapère; Tina McCluskey; Yoshiaki Furukawa; Mark Guttman; Lee-Cyn Ang; Isabelle Boileau; Jeffrey H Meyer; Stephen J Kish
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-20       Impact factor: 6.200

4.  Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study.

Authors:  Arthur L Brody; Robert Hubert; Ryutaro Enoki; Lizette Y Garcia; Michael S Mamoun; Kyoji Okita; Edythe D London; Erika L Nurmi; Lauren C Seaman; Mark A Mandelkern
Journal:  Neuropsychopharmacology       Date:  2017-03-06       Impact factor: 7.853

5.  Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28.

Authors:  K Collste; P Plavén-Sigray; H Fatouros-Bergman; P Victorsson; M Schain; A Forsberg; N Amini; S Aeinehband; S Erhardt; C Halldin; L Flyckt; L Farde; S Cervenka
Journal:  Mol Psychiatry       Date:  2017-02-14       Impact factor: 15.992

6.  Brain PET Poster Sessions PP01-M01 to PP02-N07.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

7.  Assessment of simplified methods for quantification of [18F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate.

Authors:  Nadja Van Camp; Yaël Balbastre; Anne-Sophie Herard; Sonia Lavisse; Clovis Tauber; Catriona Wimberley; Martine Guillermier; Aurélie Berniard; Pauline Gipchtein; Caroline Jan; Romina Aron Badin; Thierry Delzescaux; Philippe Hantraye; Gilles Bonvento
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-25       Impact factor: 6.200

Review 8.  Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies.

Authors:  Milky Kohno; Jeanne Link; Laura E Dennis; Holly McCready; Marilyn Huckans; William F Hoffman; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2019-01-26       Impact factor: 3.533

Review 9.  New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.

Authors:  Laura Best; Christine Ghadery; Nicola Pavese; Yen Foung Tai; Antonio P Strafella
Journal:  Curr Neurol Neurosci Rep       Date:  2019-04-02       Impact factor: 5.081

Review 10.  In vivo PET imaging of neuroinflammation in Alzheimer's disease.

Authors:  Julien Lagarde; Marie Sarazin; Michel Bottlaender
Journal:  J Neural Transm (Vienna)       Date:  2017-05-17       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.